Showing results (431-440 of 6,286) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|February 10, 2017
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome studyAvivit Cahn, Ofri Mosenzon, Deepak L Bhatt, et al.
Diabetes, Obesity & Metabolism|January 27, 2017
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trialStewart B Harris, Győző Kocsis, Rudolf Prager, et al.
Diabetes, Obesity & Metabolism|January 28, 2017
The emerging role of metformin in gestational diabetes mellitusSusan G Gray, Treasure M McGuire, Neale Cohen, et al.
Diabetes, Obesity & Metabolism|January 18, 2017
Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart diseaseTetsuro Tsujimoto, Takehiro Sugiyama, Hiroshi Kajio
Diabetes, Obesity & Metabolism|January 19, 2017
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot studyRobert R Henry, Paresh Dandona, Jeremy Pettus, et al.
Diabetes, Obesity & Metabolism|January 25, 2017
Pharmacological approach to understanding the control of insulin secretion in human isletsJean-Claude Henquin, Denis Dufrane, Valery Gmyr, et al.
Diabetes, Obesity & Metabolism|February 9, 2017
Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not directRoland H Stimson, Anna J Anderson, Lynne E Ramage, et al.
Diabetes, Obesity & Metabolism|February 12, 2017
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trialPeter G Jørgensen, Magnus T Jensen, Pernille Mensberg, et al.
Diabetes, Obesity & Metabolism|January 21, 2017
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trialBernt Johan von Scholten, Frederik Persson, Signe Rosenlund, et al.
Diabetes, Obesity & Metabolism|April 3, 2019
Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trialWenying Yang, Jianhua Ma, Guoyue Yuan, et al.
Pageof 629